University of California San Francisco
Give to UCSF
Making Sense of Scents
In a first, UCSF scientists created a molecular-level, 3D picture of how an odor molecule activates a human odorant receptor.
Why Stem Cell Therapy Might Not Work for Older Patients
Leanne Jones, PhD, is at the forefront of studying how stem cells are influenced by their surrounding environment and directed to differentiate into one type of cell or another – research that’s critical for stem cell therapies to be successful.
Can a Leading Laboratory Unlock the Cause of Gastrointestinal Disease?
Faranak Fattahi’s lab is a national leader in growing stem cells to model peripheral nerves, focusing on gastrointestinal diseases.
Can We Turn Back Time on Age-Related Diseases?
Emily Goldberg's lab studies what happens during aging to a particular set of immune cells: those embedded in fat tissue. She hypothesizes that changes to these cells during aging could be key to age-related inflammation.
Brain Injuries Drop 20% for Babies with Heart Defects
Increasing a newborn’s blood pressure after heart surgery may reduce brain injuries and increase survival for infants.
Do Sleep Medications Increase Your Chances of Dementia?
Sleep medications may increase risk of dementia for white people, though the type and amount of medication may also explain the higher probability.
This Must Be the Place
Sociologist Stacy Torres, PhD, studied a group of older adults that hung out at a Manhattan bakery. She reflects on what they taught her about survival and belonging.
The Radical Compassion of Awake Brain Surgery
On the operating table and inside the lab of a rising star in cancer neurosurgery.
Trip Therapy
Could psychedelics become mainstream medicines?
Aggressive Surgery Increases Survival with Low-Grade Brain Tumors
Resecting brain tumors called gliomas as much as possible soon after diagnosis offers a distinct survival advantage when looking at the disease trajectory 10 years later, find UCSF researchers.
30 Years On, Are We Winning the Fight Against Alzheimer’s?
UCSF experts discuss the current state of Alzheimer’s treatments and future therapies that may slow progression of the disease.
